Your browser doesn't support javascript.
loading
Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach.
Aliyu, Mansur; Zohora, Fatema Tuz; Anka, Abubakar Umar; Ali, Kashif; Maleknia, Shayan; Saffarioun, Mohammad; Azizi, Gholamreza.
Afiliação
  • Aliyu M; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, International Campus, TUMS-IC, Tehran, Iran; Department of Medical Microbiology, Faculty of Clinical Science, College of Health Sciences, Bayero University, Kano, Nigeria.
  • Zohora FT; Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Malaysia.
  • Anka AU; Department of Medical Laboratory Science, College of Medical Sciences, Ahmadu Bello University, Zaria, Nigeria.
  • Ali K; Department of Pharmacy Abdul Wali, Khan University Mardan, Pakistan.
  • Maleknia S; Biopharmaceutical Research Center, AryoGen Pharmed Inc., Alborz University of Medical Sciences, Karaj, Iran.
  • Saffarioun M; Biopharmaceutical Research Center, AryoGen Pharmed Inc., Alborz University of Medical Sciences, Karaj, Iran.
  • Azizi G; Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran. Electronic address: azizi@abzums.ac.ir.
Int Immunopharmacol ; 111: 109130, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35969896
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucina-6 / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Revista: Int Immunopharmacol Assunto da revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Nigéria
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucina-6 / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Revista: Int Immunopharmacol Assunto da revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Nigéria